A phase I pharmacokinetics trial comparing PF‐05280586 (a potential biosimilar) and rituximab in patients with active rheumatoid arthritis
暂无分享,去创建一个
Stanley B. Cohen | Dolca Thomas | P. Emery | B. Gumbiner | J. Becker | M. Greenwald | D. Yin | G. Spencer-Green | Xu Meng | L. A. Melia | Ruifeng Li | S. Cohen | X. Meng